Feature Channels

Respiratory Diseases and Disorders

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2014 4:00 PM EDT

Medicine

Channels:

Combination Therapy for COPD Associated With Better Outcomes

Among older adults with chronic obstructive pulmonary disease (COPD), particularly those with asthma, newly prescribed long-acting beta-agonists (LABAs) and inhaled corticosteroid combination therapy, compared with newly prescribed LABAs alone, was associated with a lower risk of death or COPD hospitalization, according to a study in the September 17 issue of JAMA.

View | Comment

Medicine

Channels:

Keywords:

Expert Available to Discuss Respiratory Virus Affecting Children Nationwide

View | Comment

Medicine

Channels:

Keywords:

Patients with Non-Small Cell Lung Cancer (NSCLC) Who Have Never Smoked or Who Have Quit Smoking Have Lower Risk of Developing Secondary Primary Lung Cancers Than Current Smokers

Non-small cell lung cancer (NSCLC) survivors who never smoked or who are former smokers at the time of diagnosis have a lower risk of developing secondary primary lung cancers (SPLC) compared to those who are current smokers, suggesting that increased tobacco exposure is associated with a higher risk of SPLC, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

View | Comment

Medicine

Channels:

Keywords:

PTSD and Respiratory Illness: A Signature Long-Term Problem of 9/11 Responders

170BenjaminLuft.JPG

According to the findings from research conducted over the past several years at Stony Brook Medicine’s World Trade Center Health Program, as many as 60 percent of 9/11 World Trade Center responders continue to experience clinically significant symptoms of post-traumatic stress disorder (PTSD) and lower respiratory illness.

View | Comment

Medicine

Channels:

Keywords:

Study Sheds Light on Asthma and Respiratory Viruses

HoltzmanMichael_mug_primary.jpg

In a new study that compared people with and without asthma, researchers from Washington University School of Medicine in St. Louis found no difference in the key immune response to viruses in the lungs and breathing passages. The work suggests that a fundamental antiviral defense mechanism is intact in asthma. This means that another aspect of the immune system must explain the difficulty people with asthma have when they encounter respiratory viruses.

View | Comment

Medicine

Channels:

Keywords:

New Targets for Treating Pulmonary Hypertension Found

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago. Their findings are reported in the American Journal of Respiratory and Critical Care Medicine.

View | Comment

Medicine

Channels:

Keywords:

Caffeine Therapy for Apnea of Prematurity Does Not Have Long-Term Harmful Effects on Sleep

Caffeine therapy for apnea of prematurity has no long-term harmful effects on sleep or control of breathing, according to a new study of 201 preterm children assessed at ages 5-12, the first study in humans to examine the long-term effects of neonatal caffeine treatment on sleep regulation and ventilatory control.

View | Comment

Medicine

Channels:

Keywords:

A Minimally Invasive, High-Performance Intervention for Staging Lung Cancer

Endoscopic biopsy of lymph nodes between the two lungs (mediastinum) is a sensitive and accurate technique that can replace mediastinal surgery for staging lung cancer in patients with potentially resectable tumours.

View | Comment

Medicine

Channels:

Keywords:

Oncology Experts Mark 20 Years of Evidence-Based Decision-Making in Small Cell Lung Cancer

NCCN has published the 20th annual edition of its NCCN Guidelines® for Small Cell Lung Cancer, marking the first 20th edition of the eight original NCCN Guidelines published in November 1996.

View | Comment